Report Overview
- Understand the latest market trends and future growth opportunities for the Diabetes Diagnostics industry globally with research from the Global Industry Reports team of in-country analysts – experts by industry and geographic specialization.
- Key trends are clearly and succinctly summarized alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight, and confident growth projections.
- The report will cover the overall analysis and insights in relation to the size and growth rate of the “Diabetes Diagnostics Market” by various segments at a global and regional level for the 2010-2030 period, with 2010-2021 as historical data, 2022 as a base year, 2023 as an estimated year and 2023-2030 as forecast period.
Description:
- The global market for Diabetes Diagnostics estimated at US$30.8 Billion in the year 2022, is projected to reach a revised size of US$59.4 Billion by 2030, growing at a CAGR of 8.6% over the period 2022-2030.
- Test Strips, one of the segments analyzed in the report, is projected to record 8.7% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Lancets segment is estimated at 7.9% CAGR for the next 8-year period.
- The Diabetes Diagnostics market in the U.S. is estimated at US$11.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2022 to 2030.Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 7.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.
- The following segments for both the U.S. and the European diabetes markets are included within this report: blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes, and insulin pumps.
- The European diabetes care market is increasing and growth is expected to continue over the forecast period, driven by increasing unit sales and moderated by ASP depreciation. The primary driver of growth will be the expanding diabetic population in Europe and the increasing number of patients that require various diabetes care devices to manage their disease on a daily basis. The largest segment in the diabetes care market was the insulin market, which accounted for over 44% of the total market value. The insulin market includes long-acting insulin, ultra-long-acting insulin, rapid-acting insulin, premixed insulin, and human insulin.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact and Global Slowdown Analysis
- Analysis of US inflation reduction act 2022
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data up to 2015
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
The Report Includes:
- In-depth exploration of the industry, encompassing definitions, classifications, and the industry’s interconnected structure.
- Examination of pivotal supply-side and demand trends.
- Detailed breakdown of both international and local products.
- Insight into historical volume and value dimensions, along with market shares of companies and brands.
- Five-year predictions regarding market trends and growth.
- A robust and transparent research methodology conducted within the country.
- A blend of qualitative and quantitative analysis, grounded in segmentation that considers economic and non-economic aspects.
- Provision of market value data (in USD Billion) for every segment and sub-segment.
- Geographical, regional, national, and state-wise analysis.
- A succinct overview of the commercial potential inherent in products, technologies, and applications.
- Company profiles of key market players operating within the product category.
- Descriptions of attributes and manufacturing processes.
- Segmentation based on type, application, end-users, regions, and other factors.
- Discussion about the current state, challenges, innovations, and future requirements of the market.
- Examination of the market based on application and product sizes: utility-scale, medium scale, and small-scale.
- Country-specific insights and analyses for major countries and regions.
- Coverage of historical context, pivotal industrial developments, and regulatory frameworks.
- Analysis of competitive movements, including agreements, expansions, new products, and mergers & acquisitions.
- Exploration of opportunities for stakeholders and a depiction of the competitive landscape among market leaders.
- Specialized coverage of significant global events, such as the Russia-Ukraine war, global inflation, China’s “zero-Covid” policy shift, supply chain disruptions, trade tensions, and the risk of recession.
- Evaluation of global competitiveness and market shares among key competitors.
- Presence assessment across various geographical markets: Strong, Active, Niche, Trivial.
- Online, interactive, peer-to-peer collaborative updates.
- Access to digital archives and the Market Research Platform.
- Complimentary updates for a two-year period.
Reports Scope and Segments:
| Report Attribute | Details |
| Market size value in 2022 | USD 30.8 Billion |
| Revenue forecast in 2030 | USD 59.4 Billion |
| Growth Rate | CAGR of 8.3% from 2023 to 2030 |
| Base year for estimation | 2022 |
| Historical data | 2015 – 2021 |
| Forecast period | 2023 – 2030 |
| Quantitative units | Revenue in USD million and CAGR from 2023 to 2030 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, trends, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews. Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Segments covered | Product, Type, Technology, Application, Region |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East and Africa and rest of the world |
| Country scope | United States, China, Japan, Germany, India, United Kingdom, France, Brazil, Italy, Canada, South Korea, Australia, Russia, Spain, Mexico, Indonesia, Netherlands, Switzerland, Saudi Arabia, Turkey, Taiwan, Poland, Sweden, Belgium, Thailand, Austria, Nigeria, Argentina, United Arab Emirates, Iran, Norway, Israel, Ireland, Malaysia, Denmark, Singapore, Philippines, Pakistan, Finland, Chile, Vietnam, Greece, Czech Republic, Romania, Portugal, Peru, New Zealand, Hungary, Iraq, Bangladesh, Qatar, Kuwait, Ukraine, Egypt, Kazakhstan, Colombia, Angola, Algeria, Morocco, Slovakia, Oman, Puerto Rico, Ethiopia, Sudan, Kenya, Ghana, Dominican Republic, Myanmar, Tanzania, Ecuador, Belarus, Guatemala, Lithuania, Latvia, Sri Lanka, Nepal, Lebanon, Slovenia, Bahrain, Libya and others |
| Key companies profiled | 77 ELEKTRONIKA KFT.; A.Menarini Diagnostics Ltd.; Abbott Diabetes Care, Inc.; Acon Laboratories, Inc.; AgaMatrix, Inc.; ALTUCELL; Apex Biotechnology Corporation; Arkray, Inc.; Ascensia Diabetes Care Holdings AG; AstraZeneca; B. Braun Melsungen AG; Bayer AG; Beckman Coulter, Inc.; Becton, Dickinson and Company; BIOCON; BioMérieux SA; BIONIME Corporation; Bio-Rad Laboratories, Inc.; BioTelemetry, Inc.; BOEHRINGER INGELHEIM INTERNATIONAL GMBH; Chembio Diagnostic Systems, Inc.; Companion Medical; Danaher Corp.; Dexcom, Inc.; DiaSorin S.p.A.; Diazyme Laboratories, Inc.; Drägerwerk AG & Co. KGaA; EKF Diagnostics Holdings Plc; EMBECTA CORP.; Erba Mannheim; F.Hoffmann-La-Ltd.; GlucoRx Limited; HemoCue® AB; Insulet Corporation; i-SENS, Inc.; Johnson & Johnson; LifeScan, Inc.; Lilly; MedTest Holdings, Inc.; Medtronic PLC; Menarini Group; MERCK KGAA; Miraca Holdings Inc.; Nemaura Medical Inc.; NEXTCELL PHARMA AB; Nipro Corporation; Nova Biomedical Corporation; NOVARTIS AG; NOVO NORDISK A/S; OSANG Healthcare Co., Ltd.; Pointe Scientific, Inc.; PTS Diagnostics; Randox Laboratories; Roche Diabetes Care, Inc.; Sannuo Biosensor Co., Ltd.; Sanofi S.A.; Sanwa Kagaku Kenkyusho Co, Ltd.; Senseonics Holdings, Inc.; Siemens Healthineers; Sinocare, Inc.; Sysmex Corporation; TaiDoc Technology Corporation; Takeda; Tandem Diabetes Care, Inc.;Terumo Corporation; Tosoh Bioscience, Inc.; Trinity Biotech PLC; Trividia Health, Inc.; Valeritas Holding Inc.; Werfen Group; Ypsomed Holdings; Zenotech Laboratories Ltd. and others |
| Customization scope | Free report customization (equivalent up to 20 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Report Format | PDF, PPT, Excel & Online User Account |
Diabetes Diagnostics Market By Product:
-
- BGM Devices
- Self-Monitoring Devices
- Blood Glucose Meter
- Testing Strips
- Lancets
- Self-Monitoring Devices
-
- Continuous Glucose Monitoring Devices
- Sensors
- Transmitters
- Receiver
- Continuous Glucose Monitoring Devices
- Insulin Delivery Devices
- BGM Devices
- Pumps
- Pens
- Syringes
- Jet Injectors
Diabetes Diagnostics Market By Distribution Channels:
- Hospitals Pharmacies
- Retail Pharmacies
- Diabetes Clinics/ Centers
- Online Pharmacies
- Others
Diabetes Diagnostics Market By End Use:
- Hospitals
- Home-care
- Diagnostic Centers
Diabetes Diagnostics Market By Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- Rest of the world
Companies Covered in Diabetes Diagnostics Market Report:
| 77 ELEKTRONIKA KFT. | Lilly |
| A.Menarini Diagnostics Ltd. | MedTest Holdings, Inc. |
| Abbott Diabetes Care, Inc. | Medtronic PLC |
| Acon Laboratories, Inc. | Menarini Group |
| AgaMatrix, Inc. | MERCK KGAA |
| ALTUCELL | Miraca Holdings Inc. |
| Apex Biotechnology Corporation | Nemaura Medical Inc. |
| Arkray, Inc. | NEXTCELL PHARMA AB |
| Ascensia Diabetes Care Holdings AG | Nipro Corporation |
| AstraZeneca | Nova Biomedical Corporation |
| B. Braun Melsungen AG | NOVARTIS AG |
| Bayer AG | NOVO NORDISK A/S |
| Beckman Coulter, Inc. | OSANG Healthcare Co., Ltd. |
| Becton, Dickinson and Company | Pointe Scientific, Inc. |
| BIOCON | PTS Diagnostics |
| BioMérieux SA | Randox Laboratories |
| BIONIME Corporation | Roche Diabetes Care, Inc. |
| Bio-Rad Laboratories, Inc. | Sannuo Biosensor Co., Ltd. |
| BioTelemetry, Inc. | Sanofi S.A. |
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH | Sanwa Kagaku Kenkyusho Co, Ltd. |
| Chembio Diagnostic Systems, Inc. | Senseonics Holdings, Inc. |
| Companion Medical | Siemens Healthineers |
| Danaher Corp. | Sinocare, Inc. |
| Dexcom, Inc. | Sysmex Corporation |
| DiaSorin S.p.A. | TaiDoc Technology Corporation |
| Diazyme Laboratories, Inc. | Takeda |
| Drägerwerk AG & Co. KGaA | Tandem Diabetes Care, Inc. |
| EKF Diagnostics Holdings Plc | Terumo Corporation |
| EMBECTA CORP. | Tosoh Bioscience, Inc. |
| Erba Mannheim | Trinity Biotech PLC |
| F.Hoffmann-La-Ltd. | Trividia Health, Inc. |
| GlucoRx Limited | Valeritas Holding Inc. |
| HemoCue® AB | Werfen Group |
| Insulet Corporation | Ypsomed Holdings |
| i-SENS, Inc. | Zenotech Laboratories Ltd. |
| Johnson & Johnson | Others |
| LifeScan, Inc. |
After Sales Support
- Every updated edition of the report and full data stack will be provided at no extra cost for 24 months.
- Latest 2022 base year report.
- Free Updated edition of 2023 every quarter without any hidden cost.
- No user limitation for the report. Unlimited access within the organization.
- Unrestricted post-sales support at no additional cost
- Free report customization (equivalent up to 10 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
- Global Industry Reports will support your post-purchase for a period of 24 months to answer any of your queries related to the following market and to provide you any more data needed, for your analysis.
- Option to purchase regional or some selected Chapters from the report.
Key questions that are answered in this report
- What is the estimated value of the Global Diabetes Diagnostics in 2023?
- What is the growth rate of the Global Market for Diabetes Diagnostics in 2023?
- What is the size of the Global Market for Diabetes Diagnostics in US, EUROPE, G20 countries?
- Who are the key companies in the Global Market for Diabetes Diagnostics?
- Which region is expected to hold the highest share in the Diabetes Diagnostics Market?
- Who are the top key players in the Diabetes Diagnostics Market?
- Which segment is expected to hold the largest market share in the Diabetes Diagnostics Market by 2030?
